Unraveling Neuroimmune Disorders: From Pathogenic Pathways to Biomarker-Driven Precision Medicine
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: 20 May 2026 | Viewed by 842
Special Issue Editor
2. Fondazione Policlinico Universitario “A. Gemelli” IRCCS, 00168 Rome, Italy
Interests: immunology; autoimmunity; inflammation; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neuroimmune disorders represent a huge burden for society. The pathogenetic mechanisms arise from the complexity of interactions between the immune system dysregulated or autoimmune response that, through autoantibodies and/or neuroimmune-related cells (T cells, B cells, neutrophils, and macrophages), mediates inflammatory damage targeting central or peripheral nervous system. Prominent examples of neuroimmune disorders encompass multiple sclerosis, miasthenia gravis, and neuromyelitis optica. In these conditions, inflammation, the long arm of innate immunity, may be considered the mediator of the final effects of deregulation. Neuroinflammatory and neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis show dysregulated neuroimmune and inflammatory responses, with the activation of neurons, glial cells, and infiltration of peripheral immune cells into the brain thanks to a circuit involving proinflammatory cytokines, chemokines, and neurotoxic mediators.
Accordingly, besides the assessment of specific autoantibodies when the autoantigen is known, cellular and molecular biomarkers are largely involved in the diagnosis, prognosis, response to therapies, and follow-up for a prediction of changes in disease activity. Taking into account the individual and genetic susceptibility as well as the wide range of environment risk factors that concur with the pathogenesis, the importance of research to set up and validate novel, effective, and personalized biomarkers of neuroimmune conditions stands alone. This Special Issue is devoted to the most recent results aimed at exploiting the clinical potential of biomarkers measuring the disordered immune response.
Potential topics include, but are not limited to, the following:
- Innate immunity;
- Adaptive immunity;
- Inflammation;
- Autoantibodies;
- Peptides;
- Cytokines;
- Receptors;
- Leukocytes;
- Extracellular vesicles;
- Signal transduction;
- Apoptosis.
Dr. Mariapaola Marino
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- innate immunity
- adaptive immunity
- inflammation
- autoantibodies
- peptides
- cytokines
- receptors
- leukocytes
- extracellular vesicles
- signal transduction
- apoptosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
